Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 3Triple Negative Breast Neoplasms 2Lymphoma, Non-Hodgkin 2Breast Neoplasms 2rrCLL 1Recurrence 1Pancreatic Neoplasms 1Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Breast Neoplasms, Male 1Advanced Malignant Solid Neoplasm 1

Interventions

Rituximab 63Cyclophosphamide 57fludarabine phosphate 40fludarabine 37ibrutinib 28Lenalidomide 26Bendamustine Hydrochloride 26Filgrastim 20venetoclax 19obinutuzumab 17Bortezomib 17Peripheral Blood Stem Cell Transplantation 15Etoposide 12Biopsy 12Tacrolimus 11Specimen Handling 11Melphalan 11Interleukin-2 10tanespimycin 9Radiotherapy 9Cytarabine 9aldesleukin 8Whole-Body Irradiation 8Magnetic Resonance Spectroscopy 8idelalisib 7Vorinostat 7Paclitaxel 7Mycophenolic Acid 7Ipilimumab 7Cyclosporine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Lymphocytic, Chronic, B-Cell × dinaciclib × Clear all
NCT01650727 2015-02-10

A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)

Merck Sharp & Dohme LLC

Phase 1 Completed
5 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡